Enrico Montefusco

2.9k total citations
68 papers, 1.4k citations indexed

About

Enrico Montefusco is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, Enrico Montefusco has authored 68 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Hematology, 37 papers in Genetics and 18 papers in Rheumatology. Recurrent topics in Enrico Montefusco's work include Chronic Myeloid Leukemia Treatments (46 papers), Acute Myeloid Leukemia Research (28 papers) and Chronic Lymphocytic Leukemia Research (24 papers). Enrico Montefusco is often cited by papers focused on Chronic Myeloid Leukemia Treatments (46 papers), Acute Myeloid Leukemia Research (28 papers) and Chronic Lymphocytic Leukemia Research (24 papers). Enrico Montefusco collaborates with scholars based in Italy, United States and United Kingdom. Enrico Montefusco's co-authors include Franco Mandelli, Giuliana Alimena, Marco Mancini, Michele Baccarani, Maria Concetta Petti, Maria Antonietta Aloe Spiriti, Gianantonio Rosti, Roberto Latagliata, Antonio Spadea and Giuseppe Avvisati and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Enrico Montefusco

66 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Enrico Montefusco Italy	21	985	782	436	273	250	68	1.4k
Nathalie Cambier France	14	615 0.6×	725 0.9×	297 0.7×	385 1.4×	235 0.9×	41	1.1k
Nathalie Grardel France	15	848 0.9×	591 0.8×	250 0.6×	322 1.2×	160 0.6×	40	1.3k
HM Kantarjian United States	19	879 0.9×	822 1.1×	165 0.4×	358 1.3×	455 1.8×	30	1.6k
Claire Dearden United Kingdom	9	378 0.4×	531 0.7×	273 0.6×	157 0.6×	197 0.8×	16	947
Jean-Luc Laı̈ France	14	1.1k 1.2×	715 0.9×	297 0.7×	605 2.2×	234 0.9×	33	1.4k
Ferdinando Frigeri Italy	19	422 0.4×	483 0.6×	154 0.4×	211 0.8×	339 1.4×	60	1.2k
Giovanna Rege‐Cambrin Italy	21	1.4k 1.4×	893 1.1×	352 0.8×	612 2.2×	293 1.2×	70	2.0k
Andrew Duncombe United Kingdom	18	1.1k 1.1×	915 1.2×	284 0.7×	1.2k 4.5×	145 0.6×	35	2.0k
Jiří Mayer Czechia	11	748 0.8×	679 0.9×	320 0.7×	162 0.6×	161 0.6×	48	1.0k
Prajwal Boddu United States	21	734 0.7×	361 0.5×	145 0.3×	373 1.4×	371 1.5×	51	1.2k

Countries citing papers authored by Enrico Montefusco

Since Specialization

Citations

This map shows the geographic impact of Enrico Montefusco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enrico Montefusco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enrico Montefusco more than expected).

Fields of papers citing papers by Enrico Montefusco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enrico Montefusco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enrico Montefusco. The network helps show where Enrico Montefusco may publish in the future.

Co-authorship network of co-authors of Enrico Montefusco

This figure shows the co-authorship network connecting the top 25 collaborators of Enrico Montefusco. A scholar is included among the top collaborators of Enrico Montefusco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enrico Montefusco. Enrico Montefusco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mazzucconi, Maria Gabriella, Roberto Latagliata, Massimo Breccia, et al.. (2020). Anagrelide in Essential Thrombocythemia (ET): Results from 150 patients over 25 years by the “Ph1‐negative Myeloproliferative Neoplasms Latium Group”. European Journal Of Haematology. 105(3). 335–343. 10 indexed citations

Veroli, Ambra Di, Alessia Campagna, Marianna De Muro, et al.. (2018). Deferasirox in the treatment of iron overload during myeloproliferative neoplasms in fibrotic phase: does ferritin decrement matter?. Leukemia Research. 76. 65–69. 6 indexed citations

Latagliata, Roberto, Ambra Di Veroli, Pasquale Niscola, et al.. (2015). Chelation efficacy and erythroid response during deferasirox treatment in patients with myeloproliferative neoplasms in fibrotic phase. European Journal Of Haematology. 96(6). 643–649. 16 indexed citations

Antonini, Giovanni, et al.. (2011). Successful Autologous Peripheral Blood Stem Cell Transplantation in 3 Women with POEMS Syndrome: A Single Centre Experience. Blood. 118(21). 4504–4504. 1 indexed citations

Visani, Giuseppe, Massimo Breccia, Antonella Gozzini, et al.. (2010). Dasatinib, even at low doses, is an effective second‐line therapy for chronic myeloid leukemia patients resistant or intolerant to imatinib. Results from a real life‐based Italian multicenter retrospective study on 114 patients. American Journal of Hematology. 85(12). 960–963. 9 indexed citations

Iacobucci, Ilaria, Giuseppe Saglio, Gianantonio Rosti, et al.. (2006). Achieving a Major Molecular Response at the Time of a Complete Cytogenetic Response (CCgR) Predicts a Better Duration of CCgR in Imatinib-Treated Chronic Myeloid Leukemia Patients. Clinical Cancer Research. 12(10). 3037–3042. 64 indexed citations

Antonini, Giovanni, Maria Christina Cox, Enrico Montefusco, et al.. (2006). Intrathecal anti-CD20 antibody: an effective and safe treatment for leptomeningeal lymphoma. Journal of Neuro-Oncology. 81(2). 197–199. 40 indexed citations

Montefusco, Enrico, Francesco Fazi, Iole Cordone, et al.. (2001). Molecular Remission Following High-Dose Hydroxyurea and Fludarabine Plus Cytarabine in a Patient with Simultaneous Acute Myeloid Leukemia and Low-Grade Lymphoma. Leukemia & lymphoma. 40(5-6). 671–674. 10 indexed citations

Bonifazi, Francesca, Antonio De Vivo, Gianantonio Rosti, et al.. (2000). Testing Sokal's and the new prognostic score for chronic myeloid leukaemia treated with alpha-interferon. British Journal of Haematology. 111(2). 587–595. 23 indexed citations

10.

Bonifazi, Francesca, Antonio De Vivo, Gianantonio Rosti, et al.. (2000). Testing Sokal's and the new prognostic score for chronic myeloid leukaemia treated with α‐interferon. British Journal of Haematology. 111(2). 587–595. 21 indexed citations

11.

Alimena, Giuliana, Mario Lazzarino, Enrica Morra, et al.. (1996). Clinical and cytologic characteristics of blastic phase in Ph-positive chronic myeloid leukemia treated with alpha-interferon.. IRIS Research product catalog (Sapienza University of Rome). 10(4). 615–8. 5 indexed citations

12.

Greco, Giulia, Doriana Fruci, Daniele Accapezzato, et al.. (1996). Two brc-abl junction peptides bind HLA-A3 molecules and allow specific induction of human cytotoxic T lymphocytes.. PubMed. 10(4). 693–9. 75 indexed citations

13.

Pelicci, Pier Giuseppe, F D'Adamo, Daniela Diverio, et al.. (1993). Polyclonal hematopoietic reconstitution in leukemia patients at remission after suppression of specific gene rearrangements [see comments]. Blood. 82(2). 606–612. 12 indexed citations

14.

Alimena, Giuliana, Giovanna Meloni, Francesco Lo‐Coco, et al.. (1993). Management of Chronic Myeloid Leukemia in Chronic Phase with Autologous Stem Cell Transplantation and Alpha-2 Interferon: Cytogenetic and Clinical Results. Leukemia & lymphoma. 11(sup1). 281–291. 4 indexed citations

15.

Tura, S, Domenico Russo, Elisa Zuffa, et al.. (1992). A prospective comparison of α-IFN and conventional chemotherapy in Ph+ chronic myeloid leukemia. Clinical and cytogenetic results at 2 years in 322 patients. Haematologica. 77(3). 204–214. 15 indexed citations

16.

Montefusco, Enrico, G. Alimena, Maria Antonietta Aloe Spiriti, et al.. (1992). Ph-negative and bcr-negative atypical chronic myelogenous leukemia: biological features and clinical outcome. Annals of Hematology. 65(1). 17–21. 13 indexed citations

17.

Montefusco, Enrico, Francesca Romana Mauro, William Arcese, et al.. (1991). Long-term remission of T-lymphoid extramedullary blast crisis of chronic myelogenous leukemia following allogeneic bone marrow transplantation.. PubMed. 75(4). 391–3. 5 indexed citations

18.

Fabritiis, Paolo de, Giovanna Meloni, G. Alimena, et al.. (1990). Prolonged suppression of myeloid progenitor cell numbers after stopping interferon treatment for CML may necessitate delay in harvesting marrow cells for autografting.. PubMed. 6(4). 247–51. 16 indexed citations

19.

Alimena, Giuliana, Enrico Montefusco, Marco Mancini, et al.. (1989). Prolonged effect of alpha‐interferon after discontinuance of treatment in chronic myelogenous leukemia patients. European Journal Of Haematology. 43(2). 108–111. 6 indexed citations

20.

Fabritiis, Paolo de, G Meloni, F. Simone, et al.. (1988). High-dose chemotherapy and autologous stem cell infusion in patients with chronic myelogenous leukaemia in early phase of the disease. Bone Marrow Transplantation. 3. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact